GnRH analogs as a monotherapy in transgender and gender-diverse adolescents: clinical insights from a single-center study

Background: Gonadotropin-releasing hormone agonists (GnRHas) are widely used in the treatment of transgender and gender-diverse adolescents to prevent the development of undesired physical changes. However, the safety of GnRHa use remains a subject of debate and objective literature on this topic is...

Full description

Saved in:
Bibliographic Details
Main Authors: Fleur A H Lahaije, Petra A van Setten, Willemien Levels, Karlijn Becking-Malpasso, Hedi L Claahsen-van der Grinten
Format: Article
Language:English
Published: Bioscientifica 2025-08-01
Series:Endocrine Connections
Subjects:
Online Access:https://ec.bioscientifica.com/view/journals/ec/14/8/EC-25-0292.xml
Tags: Add Tag
No Tags, Be the first to tag this record!